Holen Sie sich die Stockscreener-App
9.99
0.30%
0.03
Handel nachbörslich:
10.07
0.08
+0.80%
Schlusskurs vom Vortag:
$9.96
Offen:
$10.02
24-Stunden-Volumen:
937.94K
Relative Volume:
0.75
Marktkapitalisierung:
$1.61B
Einnahmen:
$363.55M
Nettoeinkommen (Verlust:
$-78.68M
KGV:
83.25
EPS:
0.12
Netto-Cashflow:
$50.74M
1W Leistung:
-8.26%
1M Leistung:
-12.45%
6M Leistung:
-37.87%
1J Leistung:
-31.62%
1-Tages-Spanne:
$9.82
$10.11
1-Wochen-Bereich:
$9.82
$11.07
52-Wochen-Spanne:
$9.82
$19.87
Certara Inc Stock (CERT) Company Profile
Firmenname
Certara Inc
Sektor
Branche
Telefon
(415) 237-8272
Adresse
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Vergleichen Sie CERT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CERT | 9.99 | 1.61B | 363.55M | -78.68M | 50.74M | 0.12 |
| VEEV | 213.68 | 34.73B | 2.57B | 615.26M | 996.76M | 3.32 |
| SOLV | 67.12 | 11.43B | 8.25B | 404.00M | 1.52B | 0.00 |
| DOCS | 52.21 | 9.58B | 493.63M | 160.55M | 162.20M | 0.55 |
| HQY | 102.40 | 8.82B | 1.10B | 105.67M | -197.98M | 0.1475 |
| TEM | 54.06 | 8.51B | 640.44M | -743.28M | -206.93M | 0.00 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Perform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-10 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-04-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | Eingeleitet | Berenberg | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-01 | Eingeleitet | Piper Sandler | Overweight |
| 2022-01-11 | Hochstufung | Jefferies | Hold → Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-01-05 | Eingeleitet | BofA Securities | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Neutral |
| 2021-01-05 | Eingeleitet | Jefferies | Hold |
| 2021-01-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Certara Inc Aktie (CERT) Neueste Nachrichten
(CERT) Proactive Strategies - Stock Traders Daily
Certara (NASDAQ:CERT) Sets New 52-Week LowShould You Sell? - MarketBeat
Certara stock hits 52-week low at $9.98 amid market challenges - Investing.com
WASATCH ADVISORS LP Expands Stake in Certara Inc - GuruFocus.com
Soft Biotech Funding and Cost-Cutting Dragged Certara (CERT) in Q3 - Insider Monkey
Certara's SWOT analysis: biosimulation firm navigates market shifts - Investing.com India
Certara's SWOT analysis: biosimulation firm navigates market shifts By Investing.com - Investing.com Australia
Certara, Inc. (NASDAQ:CERT) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Certara (NASDAQ:CERT) Announces Earnings Results - MarketBeat
Certara, Inc. (NASDAQ:CERT) Q3 2024 Earnings Call Transcript - Insider Monkey
Forecasting The Future: 4 Analyst Projections For Certara - Benzinga
Certara (NASDAQ:CERT) Given New $12.00 Price Target at Barclays - MarketBeat
Certara price target lowered to $12 from $14 at Barclays - TipRanks
Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com
Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Certara Inc (CERT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Certara reports Q3 adjusted EPS 13c, consensus 11c - TipRanks
Certara, Inc. Reports Q3 2024 Financial Growth - TipRanks
Certara Inc Reports Q3 2024 Revenue of $94.8M, GAAP EPS Loss of $0.01, Aligns with Estimates - GuruFocus.com
Certara Reports Third Quarter 2024 Financial Results - The Manila Times
Certara Q3 Revenue Surges 11% to $94.8M, Software Growth Leads with 15% Jump | CERT Stock News - StockTitan
Objective long/short (CERT) Report - Stock Traders Daily
Certara narrows FY24 adjusted EPS view to 41c-44c from 41c-46c - TipRanks
Robert W. Baird Lowers Certara (NASDAQ:CERT) Price Target to $13.00 - MarketBeat
Certara stock target cut, maintains neutral rating amid spending concerns - Investing.com India
Certara stock target cut, maintains neutral rating amid spending concerns By Investing.com - Investing.com South Africa
Certara price target lowered to $13 from $18 at Baird - TipRanks
Drug Discovery Informatics Market Size Set to Surpass USD - GlobeNewswire
Biosimulation Market Segments, Drivers, Restraints, And Trends For 2024-2033 - EIN News
Biosimulation Market is expected to Double Its Size by Upcoming - openPR
Certara (CERT) to Release Quarterly Earnings on Wednesday - MarketBeat
Certara to Participate in the Stephens Annual Investment Conference - The Manila Times
Certara To Participate In The Stephens Annual Investment Conference - Barchart
Certara, Inc. (NASDAQ:CERT) Shares Could Be 23% Above Their Intrinsic Value Estimate - Yahoo Finance
How To Trade (CERT) - Stock Traders Daily
Certara (NASDAQ:CERT) Hits New 12-Month LowHere's Why - MarketBeat
Certara stock hits 52-week low at $10.35 amid market challenges - Investing.com
Is Certara, Inc. (NASDAQ:CERT) Potentially Undervalued? - Simply Wall St
Certara (NASDAQ:CERT) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Analysts Set Certara, Inc. (NASDAQ:CERT) Target Price at $17.08 - MarketBeat
Globe Life Inc. (NYSE:GL) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Certara appoints new director to its board By Investing.com - Investing.com Australia
Certara Appoints John Reynders as Board Member - citybiz
Certara appoints new director to its board - Investing.com India
Certara Appoints John Reynders as New Independent Board Member - The Manila Times
Certara adds pharmaceutical veteran to board By Investing.com - Investing.com UK
380,638 Shares in Certara, Inc. (NASDAQ:CERT) Bought by Kopion Asset Management LLC - MarketBeat
Barclays Lowers Certara (NASDAQ:CERT) Price Target to $14.00 - MarketBeat
Beyond The Numbers: 4 Analysts Discuss Certara Stock - Benzinga
Trading Day Review: Certara Inc (CERT) Loses Momentum, Closing at 11.24 - The Dwinnex
Certara price target lowered to $14 from $16 at Barclays - TipRanks
Finanzdaten der Certara Inc-Aktie (CERT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.40%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):